On Feb. 14, the FDA approved Aurlumyn, the nation's first treatment for severe frostbite. 

After GSK discontinued its brand-name asthma drug Flovent on Jan. 1, families and physicians are struggling to access its generic solution, CNN reported Feb. 13. 

Healthcare suppliers and food companies are veering into new business plans amid the booming market for weight loss medications, which is expected to reach $80 billion by 2030.

The FDA has granted approval to a new medicine for patients with aggressive, metastatic pancreatic adenocarcinoma. The agency began its priority review of the drug following positive phase 3 trial results.

Gilead Sciences bought a liver disease drugmaker Feb. 12 for $4.3 billion. 

Ervebo, Merck's Ebola vaccine, reduced the fatality risk among patients who previously contracted the rare disease that kills 50% of those affected, according to new research. 

Dallas-based UT Southwestern Medical Center is partnering with Pfizer to develop RNA-enhanced delivery technologies for genetic medicine therapies.

More than 2 million 2,363,168 products BD Sensi-Disc products cannot be used for Haemophilus influenzae testing, a Becton Dickinson spokesperson told Becker's.

The University of Michigan in Ann Arbor has piloted a program aimed at involving pharmacists as part of the care team for patients with hypertension. Its success has prompted the CDC to begin scaling the model for wider use.

A chemotherapy drug could potentially be a treatment for Parkinson's disease, a recent study found.